Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

meloxicam

meloxicam
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vivlodex CAPSULE, ORAL 5 mg, 10 mg    
Anjeso INJECTION, INTRAVENOUS 30 mg/mL    
Mobic TABLET, ORAL 7.5 mg, 15 mg      
VIEW MORE Other Nonsteroidal Anti-inflammatory Agents
Comments:

ORDERED FORMULATION

FORMULARY INTERCHANGE

 meloxicam micro-particles (VIVLODEX)

  • 5 mg
  • 10 mg

 meloxicam (MOBIC)

  • 7.5 mg
  • 15 mg

meloxicam (ANJESO)

  • 30 mg IV once daily

Ketorolac

  • 17-64 years AND ≥ 50 kg: 30 mg IV every 6 hours for 5 days (max daily dose: 120 mg)
  • ≥ 65 years OR < 50 kg: 15 mg IV every 6 hours for 5 days (max daily dose: 60 mg)

Mobic medication guide

NSAID -- maybe scheduled with meals.

Anjeso: Interchange to ketorolac IV for a maximum of 5 days.  If Anjeso ordered x 1 dose, ketorolac should be entered as every 6 hours x 4 doses. Ketorolac dosage should be adjusted based on patient weight, age or renal function.

Reviewed: 26 April 2016 (Vivlodex), May 2021 (Anjeso)

Last updated: Aug. 19, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved